Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the local (cervico-vaginal) and systemic (whole body) safety of vaginal immunisation with CN54gp140 glycoprotein administered 9 times over a 3 week period.
Critère d'inclusion
- HIV Infections,Acquired Immune Deficiency Syndrome